CS226950B1 - Method of preparing 1-(d-3-mercapto-2-methylpropionyl)-l-proline - Google Patents
Method of preparing 1-(d-3-mercapto-2-methylpropionyl)-l-proline Download PDFInfo
- Publication number
- CS226950B1 CS226950B1 CS790182A CS790182A CS226950B1 CS 226950 B1 CS226950 B1 CS 226950B1 CS 790182 A CS790182 A CS 790182A CS 790182 A CS790182 A CS 790182A CS 226950 B1 CS226950 B1 CS 226950B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- proline
- formula
- methylpropionyl
- compound
- mercapto
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 229960002429 proline Drugs 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- JCBJVAJGLKENNC-UHFFFAOYSA-M potassium ethyl xanthate Chemical compound [K+].CCOC([S-])=S JCBJVAJGLKENNC-UHFFFAOYSA-M 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- -1 ethoxythiocarbonyl group Chemical group 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 14
- 239000000047 product Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229930182821 L-proline Natural products 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VFVHNRJEYQGRGE-UHFFFAOYSA-N 3-acetylsulfanyl-2-methylpropanoic acid Chemical compound OC(=O)C(C)CSC(C)=O VFVHNRJEYQGRGE-UHFFFAOYSA-N 0.000 description 1
- ZVDKTPOXSAEUQU-UHFFFAOYSA-N 3-bromo-2-methylpropanoyl chloride Chemical compound BrCC(C)C(Cl)=O ZVDKTPOXSAEUQU-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- HIZCIEIDIFGZSS-UHFFFAOYSA-L trithiocarbonate Chemical compound [S-]C([S-])=S HIZCIEIDIFGZSS-UHFFFAOYSA-L 0.000 description 1
- 239000012989 trithiocarbonate Substances 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Landscapes
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Vynález se týká způsobu přípravy 1-(D-3-merkapto-2-mettiylpropionyl) -L-prolinu vzorce I ch3 The invention relates to a process for the preparation of 1- (D-3-mercapto-2-methylpropionyl) -L-proline of the formula I ch 3
HS-CHzCHCChHS-CH of CHCCh
COOH (I)COOH (I)
Látka vzorce I je v odborné literatuře známá pod generickým názvem captopril a používá se klinicky při léčení různých forem hypertenze. Mechanismus jejího antihypertenziního účinku je vysvětlován inhibičním účinkem na enzym, který převádí angiotensin I na silně vasokonstrikčně účinný angiotensin II.The compound of formula I is known in the literature under the generic name captopril and is used clinically in the treatment of various forms of hypertension. The mechanism of its antihypertensive action is explained by its inhibitory effect on the enzyme that converts angiotensin I into a potent vasoconstrictor angiotensin II.
Syntéza látky vzorce I byla popsána D. W. Cushmanem a sp. v časopise Biochemistry 16, 5484, 1977. Vychází z terc.butylesteru L-prolinu, který se acyluje 3-acetylthio-2-methylpropionovou kyselinou v dichlormethanu za přítomnosti N,N‘-dicyklohexylkarbodiimidu a v produktu se odstraní terc.butylskupina reakci s anisolem a kyselinou trifluoroctovou. Získaná směs diastereoisomerních 1- (DL-3-acetylthio-2-methylpropionyl) 2The synthesis of the compound of formula I has been described by D. W. Cushman et al. in Biochemistry 16, 5484, 1977. It starts from tert-butyl L-proline ester, which is acylated with 3-acetylthio-2-methylpropionic acid in dichloromethane in the presence of N, N'-dicyclohexylcarbodiimide, and the product removes tert-butyl by reaction with anisole. and trifluoroacetic acid. Obtained mixture of diastereoisomeric 1- (DL-3-acetylthio-2-methylpropionyl) 2
-L-prolinů se rozdělí krystalizací dicyklohexylamoniových solí a v izolovaném žádaném isomerů se odstraní S-acetylskupina působením methanolického roztoku amoniaku. Takto získaná látka vzorce I se pak čistí krystalizací své dicyklohexylamonioVé soli, ze které se uvolní působením hydrogensulfátu draselného ve směsi vody a ethylacetátu.The L-proline is separated by crystallization of the dicyclohexylammonium salts and the isolated desired isomer is removed by treatment with methanolic ammonia solution. The compound of formula (I) thus obtained is purified by crystallization of its dicyclohexylammonium salt from which it is liberated by treatment with potassium hydrogen sulphate in a mixture of water and ethyl acetate.
Tento zdlouhavý a náročný způsob přípravy látky vzorce I je popsán též v NSR patentové přihlášce DOS č. 2 703 828. Zde jsou též bez popisu látek a uvedení konkrétního příkladu naznačeny další možnosti přípravy látky vzorce I, například reakce l-(3-halogen-2-methylpropionyI) -prolinu se sloučeninami obsahujícími v molekule merkaptoSkupinu substituovanou různými odštěpitelnými Skupinami.This lengthy and demanding process for the preparation of the compound of formula I is also described in German Patent Application Publication No. 2 703 828. Other possibilities for the preparation of the compound of formula I, for example the reaction of 1- (3-halo- 2-methylpropionyl) -proline with compounds containing a mercapto group substituted with various leaving groups in the molecule.
Využití 1- (3-halogen-2-methylpr opionyl) -L-prolinů pro syntézu látky vzorce I je podstatou československého patentu č. 219 935. V této přihlášce je popsána příprava 1-(D-3-brom-2-methylpropionyl)-L-prolinu acylací L-prolinu 3-brom-2-metliylpropionylchloridem a jeho převedení na látku vzorce I reakcí s thiosíranem nebo trithiouhličitanem sodným a kyselou hydrolýzou neizolovaných produktů.The use of 1- (3-halo-2-methylpropionyl) -L-proline for the synthesis of the compound of formula I is the essence of the Czechoslovak patent No. 219 935. This application describes the preparation of 1- (D-3-bromo-2-methylpropionyl) -L-proline by acylating L-proline with 3-bromo-2-methylpropionyl chloride and converting it to the compound of formula I by reaction with sodium thiosulfate or trithiocarbonate and acid hydrolysis of non-isolated products.
Způsob přípravy látky vzorce I podle vy226950A process for the preparation of a compound of formula I according to 226950
228350 nálezu spočívá v prvním stupni v reakci výše zmíněného l-(D-3-brom-2-methylpropionyl)-L-prolinu, resp. jeho sodné soli se snadno dostupným O-ethyldithiokarbonátem draselným ve vodném prostředí. Reakce probíhá již při teplotě místnosti a je skončena za 16 h. Produkt, l-(D-3-ethoxythiokarbonylťhio-2-methylpropionyl)-L-prolin vzorce II C2j~ls0. CS. 5-CH2 CHCO-^228350 of the finding consists in the first step in the reaction of the above-mentioned 1- (D-3-bromo-2-methylpropionyl) -L-proline, respectively. its sodium salts with readily available potassium O-ethyldithiocarbonate in an aqueous medium. The reaction proceeds at room temperature and is complete in 16 h. The product, 1- (D-3-ethoxythiocarbonylthio-2-methylpropionyl) -L-proline of formula II C 2 H -1 with 0. CS. 5-CH 2 CHCO 3
COOH (K) se získá okyselením a odsátím nebo se přečistí rozpuštěním ve vodném roztoku uhličitanu sodného, filtrací roztoku s aktivním uhlím a okyselením filtrátu. Takto se získá dostatečně čistý krystalický produkt vzorce II ve výtěžku až 90 % teorie. Meziprodukt vzorce II se pak převádí na látku vzorce I působením amoniaku ve vodném methanolu nebo ethanolu při teplotě místnosti. Reakce je skončena do 24 h. Látka vzorce I se pak izoluje okyselením reakční směsi, vytřepáním do ethylacetátu a po oddestilování rozpouštědla krystalizací ze směsi ethylacetátu a hexanu. Čistá látka vzorce I se získá ve výtěžku až 80 % teorie.COOH (K) is obtained by acidification and aspiration or purified by dissolution in aqueous sodium carbonate solution, filtration of the activated carbon solution and acidification of the filtrate. Thus, a sufficiently pure crystalline product of formula II is obtained in a yield of up to 90% of theory. The intermediate of formula II is then converted to the compound of formula I by treatment with ammonia in aqueous methanol or ethanol at room temperature. The reaction is complete in 24 h. The compound of formula I is then isolated by acidifying the reaction mixture, shaking it into ethyl acetate and, after distilling off the solvent, by crystallization from a mixture of ethyl acetate and hexane. The pure compound of formula I is obtained in a yield of up to 80% of theory.
Výhody způsobu přípravy látky vzorce I podle vynálezu ve srovnání s dosud popsanými postupy spočívají v jednoduchosti provedení a dobré čistotě takto připravené látky vzorce I, která je příznivě ovlivněna tím, že se v posledním stupni syntézy na látku vzorce I převádí čistý, krystalický meziprodukt vzorce II.The advantages of the process according to the invention for the preparation of a compound of the formula I according to the invention are that it is simple to carry out and a good purity of the compound of the formula I thus produced, favorably influenced by converting the pure, crystalline intermediate of formula II .
Podrobnosti způsobu přípravy podle vynálezu jsou uvedeny v následujících příkladech provedení.Details of the preparation process according to the invention are given in the following examples.
Příklad 1Example 1
1- (D-3-Ethoxy thiakarbonylthio-2-methylpropionyl}-L-pr©lin1- (D-3-Ethoxythiocarbonylthio-2-methylpropionyl) -L-proline
-brom-2-methylpropionyl)-L'prolinu a 11 g uhličitanu sodného ve 100 ml vody se přidá za míchání roztok 38 g O-ethyldithiokarbonátu draselného v 80 ml vody a směs se ponechá v klidu- 16 h při teplotě místnosti. Okyselí se 10% kyselinou chlorovodíkovou, přičemž se z roztoku vyloučí produkt v olejovité nebo krystalické formě, a zahřívá se 40 minut na teplotu 70 °C. Po ochlazení se vyloučený krystalický produkt rozpustí alkalizací na pH 8 až 9 přidáním 10% roztoku uhličitanu sodného za míchání. Získaný žlutý roztok se zfiltruje s aktivním uhlím a okyselí kyselinou chlorovodíkovou na pH-bromo-2-methylpropionyl) -L'proline and 11 g of sodium carbonate in 100 ml of water are added with stirring a solution of 38 g of potassium O-ethyldithiocarbonate in 80 ml of water and the mixture is left to stand for 16 h at room temperature. It is acidified with 10% hydrochloric acid to precipitate the product in oily or crystalline form and heated at 70 ° C for 40 minutes. After cooling, the precipitated crystalline product is dissolved by alkalization to pH 8-9 by adding 10% sodium carbonate solution with stirring. The resulting yellow solution was filtered with charcoal and acidified to pH with hydrochloric acid
2. Vyloučený, produkt se odsaje, promyje vodou a suší. Získá se 49,2 g (86,1 % teorie) 1- (D-3-ethoxythiokarbonylthio-2-metihylpropiomylj-L-prolinu s t. t. 60 až 64 °C, který je dostatečně čistý pro další stupeň syntézy. Vzorek překrystalovaný z vodného ethanolu a vysušený za sníženého tlaku (13,3 Pa) po dobu 8 h mění při 53 °C krystalovou modifikaci a taje při 79 až 80 °C, (a)Dzo = -175,,3° (c = 1, ethanol). Příklad 22. The precipitated product is filtered off with suction, washed with water and dried. There was obtained 49.2 g (86.1% of theory) of 1- (D-3-ethoxythiocarbonylthio-2-methylpropiomyl) -L-proline having a melting point of 60-64 [deg.] C. which was sufficiently pure for the next step of the synthesis. ethanol and dried under reduced pressure (13.3 Pa) for 8 h at 53 ° C changes the crystal modification and melts at 79-80 ° C, ( a ) D 2 = -175.3 ° (c = 1, ethanol Example 2
1- (D-3-Merkapto-2-methylpropionyl) -L-prolin g l-(D-3-ethoxythiékarbonylthio-2-methylpropionyl)-L-prolinu se rozpustí v 50 ml ethanolu a k roztoiku se přidá 90 ml 25% vodného amoniaku. Směs se ponechá v klidu při teplotě místnosti 24 h, zahustí se na odparce za sníženého tlaku na objem asi 60 ml 'a po zředění přidáním 60 ml vody se protřepe dvakrát s etherem. Oddělený vodný roztok se okyselí kyselinou chlorovodíkovou na pH 2 a vyloučený olejovitý produkt se vytřepe do ethylacetátu. Ethylacetátový roztok se promyje nasyceným roztokem chloridu sodného, vysuší bezvodým síranem hořečnatým a ethylacetát se oddestiluje za sníženého tlaku. Krystalický produkt se získá rozpuštěním odparku v ethylacetátu a přidáním hexanu. Získá se 27,5 g (78,7 % teorie) l-(D-3-merkapto-2-methylpropionyl)-L-prolinu s t. t. 103 až 105 °C, («)D 20 = —130,7° (c — =1, ethanol).1- (D-3-Mercapto-2-methylpropionyl) -L-proline 1- (D-3-ethoxythiocarbonylthio-2-methylpropionyl) -L-proline is dissolved in 50 ml of ethanol and 90 ml of 25% aq. ammonia. The mixture is allowed to stand at room temperature for 24 h, concentrated on a evaporator under reduced pressure to a volume of about 60 ml and, after dilution by addition of 60 ml of water, is shaken twice with ether. The separated aqueous solution was acidified to pH 2 with hydrochloric acid and the resulting oily product was taken up in ethyl acetate. The ethyl acetate solution was washed with saturated brine, dried over anhydrous magnesium sulfate, and ethyl acetate was distilled off under reduced pressure. The crystalline product is obtained by dissolving the residue in ethyl acetate and adding hexane. There were obtained 27.5 g (78.7% of theory) of l- (D-3-mercapto-2-methyl-propionyl) -L-proline with mp 103-105 ° C ( «) D 20 = -130.7 ° ( c = 1, ethanol).
K roztoku 52,8 g monohydrátu l-(D-3-To a solution of 52.8 g of 1- (D-3-) monohydrate
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS790182A CS226950B1 (en) | 1982-11-05 | 1982-11-05 | Method of preparing 1-(d-3-mercapto-2-methylpropionyl)-l-proline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS790182A CS226950B1 (en) | 1982-11-05 | 1982-11-05 | Method of preparing 1-(d-3-mercapto-2-methylpropionyl)-l-proline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS226950B1 true CS226950B1 (en) | 1984-04-16 |
Family
ID=5428934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS790182A CS226950B1 (en) | 1982-11-05 | 1982-11-05 | Method of preparing 1-(d-3-mercapto-2-methylpropionyl)-l-proline |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS226950B1 (en) |
-
1982
- 1982-11-05 CS CS790182A patent/CS226950B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4154935A (en) | Halogen substituted mercaptoacylamino acids | |
| DE2759862C2 (en) | ||
| EP0022219B1 (en) | 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them | |
| JPS643870B2 (en) | ||
| HU185576B (en) | Process for producing n-acylized l-proline derivatives | |
| US4320057A (en) | Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones | |
| IE50839B1 (en) | Novel processes for preparing proline derivatives and analogous compounds | |
| US4332725A (en) | Process for the preparation of 1-[3-mercapto-(2S)-methylpropionyl]-pyrrolidine-(2S)-carboxylic acid | |
| JP2691442B2 (en) | Novel proline derivative | |
| US4296033A (en) | 4-Azido-1-mercaptoacyl proline | |
| JPH0316343B2 (en) | ||
| WO1996030354A1 (en) | Epoxysuccinic acid derivatives | |
| CS226950B1 (en) | Method of preparing 1-(d-3-mercapto-2-methylpropionyl)-l-proline | |
| JP2019199446A (en) | Method of producing s-ica ribosylhomocysteine | |
| EP0174358A1 (en) | Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof | |
| US4290952A (en) | Aryl-1-mercaptoalkanoylproline and homoproline derivatives | |
| AU637719B2 (en) | Process for preparing 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-proline | |
| SK19993A3 (en) | Process for preparing 1-(3-mercapto-(2s)-methyl-propionyl)- -l-proline | |
| US4308388A (en) | 4-Azido-1-mercaptoacyl pipecolic acid | |
| HU179780B (en) | Process for preparing thiazolidine-carboxylic acid derivatives | |
| KR820001832B1 (en) | Process for preparing halogen substituted mercaptoacylamino acids | |
| KR100397491B1 (en) | Optically active (S)-benzoxazine derivatives and preparing method of the same | |
| FR2519002A1 (en) | NEW BICYCLIC COMPOUNDS AND PROCESS FOR PREPARING THE SAME | |
| AT371435B (en) | METHOD FOR PRODUCING NEW ALKYLENE IMIN DERIVATIVES AND THEIR SALTS | |
| SU351369A1 (en) | METHOD OF OBTAINING ALKALOIDS |